Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell membranes and surface structures are essential components that maintain the physical integrity and physiological function of bacteria and fungi (Wikipedia, 2023). These structures include the cytoplasmic membrane, which acts as a selective permeability barrier, and specialized surface components like lipopolysaccharides (LPS) in Gram-negative bacteria or ergosterol in fungi (StatPearls, 2023). They are involved in critical processes such as energy production via the electron transport chain, nutrient uptake, and the anchoring of cell wall biosynthetic machinery (NCBI, 2022). Therapeutic agents like polymyxins and lipopeptides target these structures to induce membrane depolarization or physical disruption, leading to rapid microbial cell death (PubMed, 2021). Because these structures often differ significantly from mammalian cell membranes, they provide a basis for selective toxicity, although some agents still exhibit significant side effects like nephrotoxicity (NIH, 2023). Understanding these structures is vital for developing new antimicrobial strategies to combat multi-drug resistant pathogens (Nature Reviews Microbiology, 2020).
Drugs targeting these structures typically function through physical disruption of the lipid bilayer or binding to specific membrane components. Polymyxins (e.g., Colistin) bind to the lipid A portion of lipopolysaccharides in Gram-negative bacteria, displacing divalent cations and disrupting the outer membrane (StatPearls, 2023). Daptomycin inserts into the cytoplasmic membrane of Gram-positive bacteria in a calcium-dependent manner, leading to potassium efflux and rapid depolarization (NCBI, 2022). Polyene antifungals like Amphotericin B bind to ergosterol in fungal membranes, forming pores that cause the leakage of intracellular contents and subsequent cell death (PubMed, 2021).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membrane and surface structures.